Myomo, Inc. (MYO) 10-Year Financial Performance & Capital Metrics

MYO • • Industrial / General

HealthcareMedical DevicesOrthopedic & Musculoskeletal DevicesJoint Reconstruction & Orthopedic Implants

AboutMyomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.Show more

Revenue $33M +69.2%
EBITDA -$5M +29.6%
Net Income -$6M +24.1%
EPS (Diluted) -0.16 +42.9%
Gross Margin 71.23% +4.0%
EBITDA Margin -16.68% +58.4%
Operating Margin -19.07% +55.4%
Net Margin -19% +55.1%
ROE -36.7% +65.4%
ROIC -83.37% +71.1%
Debt/Equity 0.33 +390.3%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 53.4%
✓Trading at only 1.4x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 16 (bottom 16%)
✗Shares diluted 28.0% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y42.95%

5Y53.36%

3Y32.93%

TTM64.99%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-43.37%

EPS CAGR

10Y-

5Y-

3Y-

TTM-28.79%

ROCE

10Y Avg-131.83%

5Y Avg-89.85%

3Y Avg-76.88%

Latest-30.15%

Peer Comparison

Joint Reconstruction & Orthopedic Implants

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SYKStryker Corporation	138.62B	362.49	46.71	10.23%	12.07%	13.51%	2.52%	0.68
SNNSmith & Nephew plc	13.96B	32.89	34.99	4.7%	6.88%	14.44%	4.34%	0.63
ZBHZimmer Biomet Holdings, Inc.	17.59B	88.75	20.03	3.85%	10.05%	6.31%	6.5%	0.50
CNMDCONMED Corporation	1.32B	42.55	9.99	5%	4.75%	6.35%	11.68%	0.94
DHAIDIH Holding US, Inc.	6.7K	0.00	-0.00	-2.5%	-13.8%
LFWDLifeward Ltd.	13.23M	0.72	-0.22	85.24%	-121.82%	-233.98%		0.05
ANIKAnika Therapeutics, Inc.	137.43M	9.53	-2.49	-0.73%	-40.83%	-22.5%		0.17
SNWVSANUWAVE Health, Inc.	237.99M	27.75	-3.95	59.99%	-17.06%		0.83%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	689.67K	1.1M	1.56M	2.44M	3.84M	7.58M	13.86M	15.56M	19.24M	32.55M
Revenue Growth %	-0.24%	0.6%	0.41%	0.57%	0.57%	0.98%	0.83%	0.12%	0.24%	0.69%
Cost of Goods Sold+	244.41K	282.16K	505.28K	728.28K	917.62K	2.6M	3.54M	5.3M	6.06M	9.37M
COGS % of Revenue	0.35%	0.26%	0.32%	0.3%	0.24%	0.34%	0.26%	0.34%	0.31%	0.29%
Gross Profit+	445.26K	821.11K	1.05M	1.72M	2.92M	4.98M	10.31M	10.25M	13.18M	23.19M
Gross Margin %	0.65%	0.74%	0.68%	0.7%	0.76%	0.66%	0.74%	0.66%	0.69%	0.71%
Gross Profit Growth %	-0.37%	0.84%	0.28%	0.63%	0.7%	0.71%	1.07%	-0.01%	0.29%	0.76%
Operating Expenses+	3.98M	4.1M	7.6M	12.24M	13.72M	15.49M	20.58M	20.93M	21.41M	29.39M
OpEx % of Revenue	5.77%	3.71%	4.88%	5.01%	3.57%	2.04%	1.49%	1.35%	1.11%	0.9%
Selling, General & Admin	3.22M	2.98M	5.85M	10.41M	11.55M	13.82M	18.02M	18.44M	18.78M	24.62M
SG&A % of Revenue	4.67%	2.7%	3.75%	4.26%	3.01%	1.82%	1.3%	1.19%	0.98%	0.76%
Research & Development	869.13K	1.12M	1.75M	1.84M	2.16M	1.67M	2.56M	2.48M	2.64M	4.77M
R&D % of Revenue	1.26%	1.02%	1.12%	0.75%	0.56%	0.22%	0.18%	0.16%	0.14%	0.15%
Other Operating Expenses	0	0	0	0	0	0	-16.95K	-1.1K	0	0
Operating Income+	-3.53M	-3.28M	-6.55M	-10.53M	-10.8M	-10.5M	-10.27M	-10.67M	-8.23M	-6.21M
Operating Margin %	-5.12%	-2.97%	-4.2%	-4.31%	-2.81%	-1.38%	-0.74%	-0.69%	-0.43%	-0.19%
Operating Income Growth %	-0.29%	0.07%	-1%	-0.61%	-0.03%	0.03%	0.02%	-0.04%	0.23%	0.25%
EBITDA+	-3.53M	-3.27M	-6.54M	-10.46M	-10.7M	-10.39M	-9.93M	-10.13M	-7.71M	-5.43M
EBITDA Margin %	-5.12%	-2.96%	-4.19%	-4.28%	-2.79%	-1.37%	-0.72%	-0.65%	-0.4%	-0.17%
EBITDA Growth %	-0.29%	0.07%	-1%	-0.6%	-0.02%	0.03%	0.04%	-0.02%	0.24%	0.3%
D&A (Non-Cash Add-back)	5.31K	7.73K	11.41K	69.68K	95.12K	108.67K	335.96K	542.63K	517.68K	776.97K
EBIT	-3.53M	-3.28M	-6.55M	-10.53M	-10.8M	-11.09M	-10.27M	-10.67M	-8.23M	-5.82M
Net Interest Income+	0	-342.02K	-5.53M	175.41K	-113.63K	-474.71K	1.61K	88.73K	410.27K	388.59K
Interest Income	196.06K	0	0	0	-	0	1.61K	88.73K	410.27K	388.59K
Interest Expense	0	342.02K	358.92K	358.92K	113.63K	474.71K	0	0	0	0
Other Income/Expense	-196.06K	-342.02K	-5.55M	211.68K	81.99K	-1.06M	-15.34K	21.12K	239.99K	388.59K
Pretax Income+	-3.73M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.28M	-10.65M	-7.99M	-5.82M
Pretax Margin %	-5.41%	-3.28%	-7.76%	-4.22%	-2.79%	-1.52%	-0.74%	-0.68%	-0.42%	-0.18%
Income Tax+	0	0	0	0	0	0	88.93K	69.94K	156K	365.62K
Effective Tax Rate %	1.2%	1%	1%	1%	1%	1%	1.01%	1.01%	1.02%	1.06%
Net Income+	-4.48M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.37M	-10.72M	-8.15M	-6.18M
Net Margin %	-6.5%	-3.28%	-7.76%	-4.22%	-2.79%	-1.52%	-0.75%	-0.69%	-0.42%	-0.19%
Net Income Growth %	-0.27%	0.19%	-2.34%	0.15%	-0.04%	-0.08%	0.1%	-0.03%	0.24%	0.24%
Net Income (Continuing)	-3.73M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.37M	-10.72M	-8.15M	-6.18M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-134.56	-0.56	-84.05	-25.15	-19.20	-3.62	-1.78	-1.52	-0.28	-0.16
EPS Growth %	-0.27%	1%	-149.09%	0.7%	0.24%	0.81%	0.51%	0.15%	0.82%	0.43%
EPS (Basic)	-134.56	-0.56	-84.05	-25.18	-19.20	-3.62	-1.78	-1.52	-0.28	-0.16
Diluted Shares Outstanding	33.31K	6.41M	143.93K	410.15K	553.79K	3.33M	5.83M	7.05M	29.5M	37.76M
Basic Shares Outstanding	33.31K	6.41M	143.93K	409.75K	553.79K	3.33M	5.83M	7.05M	29.1M	37.76M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.37M	1.15M	13.85M	7.87M	6.15M	14.45M	19.09M	9.22M	13.65M	32.79M
Cash & Short-Term Investments	1.04M	797.17K	12.96M	6.54M	4.47M	12.24M	15.52M	5.35M	8.87M	24.87M
Cash Only	1.04M	797.17K	12.96M	6.54M	4.47M	12.24M	15.52M	5.35M	6.87M	24.37M
Short-Term Investments	0	0	0	0	0	0	0	0	1.99M	492.99K
Accounts Receivable	115.64K	114.51K	297.04K	382.26K	424.29K	924.92K	1.96M	1.9M	2.38M	3.83M
Days Sales Outstanding	61.2	37.88	69.55	57.09	40.35	44.52	51.63	44.49	45.2	42.89
Inventory	98.02K	82.44K	201.16K	256.15K	439.53K	707.11K	808.31K	1.4M	1.8M	3.17M
Days Inventory Outstanding	146.39	106.64	145.31	128.38	174.83	99.25	83.25	96.37	108.65	123.38
Other Current Assets	0	0	0	0	820.21K	0	-95.33K	573.46K	598.85K	933.38K
Total Non-Current Assets+	138.71K	511.8K	129.15K	407.1K	449.21K	263.81K	1M	946.55K	930.59K	9.45M
Property, Plant & Equipment	27.43K	21.56K	77.15K	187.51K	154.97K	263.81K	908.2K	703.03K	839.35K	8.91M
Fixed Asset Turnover	25.14x	51.17x	20.21x	13.03x	24.76x	28.75x	15.26x	22.13x	22.92x	3.65x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	52K	75K	75K	0	0	132.49K	0	0
Other Non-Current Assets	111.28K	490.24K	0	144.58K	219.24K	0	95.33K	111.03K	91.24K	539.41K
Total Assets+	1.51M	1.66M	13.97M	8.28M	6.6M	14.71M	20.1M	10.16M	14.58M	42.24M
Asset Turnover	0.46x	0.67x	0.11x	0.30x	0.58x	0.52x	0.69x	1.53x	1.32x	0.77x
Asset Growth %	-0.5%	0.1%	7.43%	-0.41%	-0.2%	1.23%	0.37%	-0.49%	0.43%	1.9%
Total Current Liabilities+	945.22K	3M	1.49M	1.86M	3.88M	2.87M	4.28M	3.6M	5.48M	10.17M
Accounts Payable	138.6K	311.08K	264.89K	426.73K	450.1K	180.5K	723.35K	569.68K	1.07M	1.17M
Days Payables Outstanding	206.99	402.41	191.35	213.87	179.04	25.34	74.5	39.22	64.67	45.59
Short-Term Debt	572.65K	2.07M	0	0	1.76M	0	0	0	0	0
Deferred Revenue (Current)	0	67.26K	168.01K	108.6K	2.95K	2.81K	192.75K	773.88K	8.51K	1000K
Other Current Liabilities	149.28K	248.56K	409.85K	292.6K	779.88K	2.08M	2.48M	1.19M	3.41M	5.14M
Current Ratio	1.45x	0.38x	9.32x	4.24x	1.58x	5.03x	4.46x	2.56x	2.49x	3.22x
Quick Ratio	1.35x	0.35x	9.19x	4.11x	1.47x	4.79x	4.27x	2.17x	2.16x	2.91x
Cash Conversion Cycle	0.6	-257.89	23.51	-28.4	36.15	118.44	60.38	101.64	89.18	120.68
Total Non-Current Liabilities+	1.9M	16.19M	44.04K	535.33K	890.46K	274.7K	402.87K	200.71K	115.16K	7.36M
Long-Term Debt	1.48M	3.38M	0	0	888.96K	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	155.15K	401.62K	200.21K	115.16K	7.36M
Deferred Tax Liabilities	0	0	0	0	888.96K	0	0	0	0	0
Other Non-Current Liabilities	425.33K	12.8M	0	0	0	118.06K	0	0	0	0
Total Liabilities	2.85M	19.19M	1.53M	1.86M	4.77M	3.14M	4.69M	3.8M	5.59M	17.53M
Total Debt+	2.05M	5.45M	0	0	2.65M	173.44K	735K	553.91K	601.3K	8.11M
Net Debt	1.01M	4.66M	-12.96M	-6.54M	-1.81M	-12.07M	-14.79M	-4.79M	-6.27M	-16.27M
Debt / Equity	-	-	-	-	1.45x	0.01x	0.05x	0.09x	0.07x	0.33x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-9.58x	-18.24x	-29.33x	-95.00x	-22.12x	-	-	-	-
Total Equity+	-1.34M	-17.53M	12.45M	6.43M	1.82M	11.57M	15.41M	6.36M	8.99M	24.71M
Equity Growth %	-2.88%	-12.1%	1.71%	-0.48%	-0.72%	5.34%	0.33%	-0.59%	0.41%	1.75%
Book Value per Share	-40.17	-2.73	86.47	15.67	3.29	3.47	2.64	0.90	0.30	0.65
Total Shareholders' Equity	-1.34M	-17.53M	12.45M	6.43M	1.82M	11.57M	15.41M	6.36M	8.99M	24.71M
Common Stock	100	112	1.11K	1.25K	57	457	687	775	2.71K	3.44K
Retained Earnings	-19.26M	-22.88M	-34.97M	-45.29M	-56.13M	-67.69M	-78.06M	-88.78M	-96.93M	-103.11M
Treasury Stock	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K
Accumulated OCI	0	-20.34K	-31.76K	-100.12K	0	-12.69K	-60.68K	43.23K	83.67K	-14.41K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-3.33M	-3.2M	-6.15M	-9.61M	-10.34M	-9.03M	-9.55M	-10.23M	-6.17M	-3.29M
Operating CF Margin %	-4.83%	-2.9%	-3.95%	-3.93%	-2.69%	-1.19%	-0.69%	-0.66%	-0.32%	-0.1%
Operating CF Growth %	-0.31%	0.04%	-0.92%	-0.56%	-0.08%	0.13%	-0.06%	-0.07%	0.4%	0.47%
Net Income	-3.73M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.37M	-10.72M	-8.15M	-6.18M
Depreciation & Amortization	5.31K	7.73K	11.41K	69.68K	95.12K	108.67K	335.96K	542.63K	517.68K	776.97K
Stock-Based Compensation	53.84K	94.09K	279.51K	814.67K	907.99K	614.3K	1.1M	1.19M	1.12M	874.44K
Deferred Taxes	0	0	-56.67K	48.92K	0	0	0	0	0	0
Other Non-Cash Items	-28.06K	5.35K	5.2M	-36.27K	-81.92K	959.13K	-19.73K	204.34K	48.31K	-17.37K
Working Capital Changes	363.96K	307.18K	505.97K	-186.57K	-550.01K	848.91K	-588.01K	-1.45M	293.21K	1.26M
Change in Receivables	115.99K	1.14K	-182.53K	-101.49K	-42.03K	-522.94K	-1.05M	47.45K	-495.6K	-1.56M
Change in Inventory	16.28K	120.59K	-161.07K	-140.82K	-213.56K	-271.55K	-118.22K	-607.4K	-384.78K	-1.4M
Change in Payables	0	364.17K	563.23K	466.19K	60.74K	1.22M	0	-711.9K	1.79M	4.69M
Cash from Investing+	-27.94K	-1.86K	-67K	-126.87K	-51.99K	-45.75K	-326.46K	-310.79K	-2.03M	259.98K
Capital Expenditures	-27.94K	-1.86K	-67K	-126.87K	-51.99K	-45.75K	-326.46K	-111.79K	-145.82K	-1.36M
CapEx % of Revenue	0.04%	0%	0.04%	0.05%	0.01%	0.01%	0.02%	0.01%	0.01%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	-126.87K	0	0	0	-199K	0	0
Cash from Financing+	1.98M	2.96M	18.38M	3.34M	8.32M	16.78M	13.17M	376.86K	9.71M	20.93M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	1.56M	2.87K	129.61K	3.34M	-73.38K	185.3K	12.07M	0	-8.12K	563.64K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-3.36M	-3.2M	-6.22M	-9.73M	-10.39M	-9.08M	-9.87M	-10.35M	-6.32M	-4.65M
FCF Margin %	-4.88%	-2.9%	-3.99%	-3.98%	-2.71%	-1.2%	-0.71%	-0.67%	-0.33%	-0.14%
FCF Growth %	-0.32%	0.05%	-0.94%	-0.56%	-0.07%	0.13%	-0.09%	-0.05%	0.39%	0.26%
FCF per Share	-100.95	-0.50	-43.22	-23.73	-18.77	-2.73	-1.69	-1.47	-0.21	-0.12
FCF Conversion (FCF/Net Income)	0.74x	0.89x	0.51x	0.93x	0.97x	0.78x	0.92x	0.95x	0.76x	0.53x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-97.2%	-109.34%	-259.69%	-172.72%	-76.9%	-98.5%	-106.17%	-36.7%
Return on Invested Capital (ROIC)	-	-	-	-	-	-	-13129.96%	-731.96%	-288.04%	-83.37%
Gross Margin	64.56%	74.42%	67.59%	70.2%	76.09%	65.71%	74.42%	65.91%	68.51%	71.23%
Net Margin	-649.9%	-327.84%	-776.04%	-422.11%	-279.15%	-152.49%	-74.86%	-68.92%	-42.34%	-19%
Debt / Equity	-	-	-	-	1.45x	0.01x	0.05x	0.09x	0.07x	0.33x
Interest Coverage	-	-9.58x	-18.24x	-29.33x	-95.00x	-22.12x	-	-	-	-
FCF Conversion	0.74x	0.89x	0.51x	0.93x	0.97x	0.78x	0.92x	0.95x	0.76x	0.53x
Revenue Growth	-24.48%	59.97%	41.29%	56.79%	57.02%	97.6%	82.72%	12.26%	23.7%	69.17%

Revenue by Segment

	2022	2023	2024
Product	14.56M	17.48M	32.55M
Product Growth	-	20.07%	86.26%
License	1M	1.76M	-
License Growth	-	76.49%	-

Frequently Asked Questions

Growth & Financials

Myomo, Inc. (MYO) reported $41.6M in revenue for fiscal year 2024. This represents a 4460% increase from $0.9M in 2014.

Myomo, Inc. (MYO) grew revenue by 69.2% over the past year. This is strong growth.

Myomo, Inc. (MYO) reported a net loss of $12.0M for fiscal year 2024.

Dividend & Returns

Myomo, Inc. (MYO) has a return on equity (ROE) of -36.7%. Negative ROE indicates the company is unprofitable.

Myomo, Inc. (MYO) had negative free cash flow of $13.8M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Myomo, Inc. (MYO) 10-Year Financial Performance & Capital Metrics

MYO • • Industrial / General

HealthcareMedical DevicesOrthopedic & Musculoskeletal DevicesJoint Reconstruction & Orthopedic Implants

Revenue $33M +69.2%
EBITDA -$5M +29.6%
Net Income -$6M +24.1%
EPS (Diluted) -0.16 +42.9%
Gross Margin 71.23% +4.0%
EBITDA Margin -16.68% +58.4%
Operating Margin -19.07% +55.4%
Net Margin -19% +55.1%
ROE -36.7% +65.4%
ROIC -83.37% +71.1%
Debt/Equity 0.33 +390.3%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 53.4%
✓Trading at only 1.4x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 16 (bottom 16%)
✗Shares diluted 28.0% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y42.95%

5Y53.36%

3Y32.93%

TTM64.99%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-43.37%

EPS CAGR

10Y-

5Y-

3Y-

TTM-28.79%

ROCE

10Y Avg-131.83%

5Y Avg-89.85%

3Y Avg-76.88%

Latest-30.15%

Peer Comparison

Joint Reconstruction & Orthopedic Implants

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SYKStryker Corporation	138.62B	362.49	46.71	10.23%	12.07%	13.51%	2.52%	0.68
SNNSmith & Nephew plc	13.96B	32.89	34.99	4.7%	6.88%	14.44%	4.34%	0.63
ZBHZimmer Biomet Holdings, Inc.	17.59B	88.75	20.03	3.85%	10.05%	6.31%	6.5%	0.50
CNMDCONMED Corporation	1.32B	42.55	9.99	5%	4.75%	6.35%	11.68%	0.94
DHAIDIH Holding US, Inc.	6.7K	0.00	-0.00	-2.5%	-13.8%
LFWDLifeward Ltd.	13.23M	0.72	-0.22	85.24%	-121.82%	-233.98%		0.05
ANIKAnika Therapeutics, Inc.	137.43M	9.53	-2.49	-0.73%	-40.83%	-22.5%		0.17
SNWVSANUWAVE Health, Inc.	237.99M	27.75	-3.95	59.99%	-17.06%		0.83%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	689.67K	1.1M	1.56M	2.44M	3.84M	7.58M	13.86M	15.56M	19.24M	32.55M
Revenue Growth %	-0.24%	0.6%	0.41%	0.57%	0.57%	0.98%	0.83%	0.12%	0.24%	0.69%
Cost of Goods Sold+	244.41K	282.16K	505.28K	728.28K	917.62K	2.6M	3.54M	5.3M	6.06M	9.37M
COGS % of Revenue	0.35%	0.26%	0.32%	0.3%	0.24%	0.34%	0.26%	0.34%	0.31%	0.29%
Gross Profit+	445.26K	821.11K	1.05M	1.72M	2.92M	4.98M	10.31M	10.25M	13.18M	23.19M
Gross Margin %	0.65%	0.74%	0.68%	0.7%	0.76%	0.66%	0.74%	0.66%	0.69%	0.71%
Gross Profit Growth %	-0.37%	0.84%	0.28%	0.63%	0.7%	0.71%	1.07%	-0.01%	0.29%	0.76%
Operating Expenses+	3.98M	4.1M	7.6M	12.24M	13.72M	15.49M	20.58M	20.93M	21.41M	29.39M
OpEx % of Revenue	5.77%	3.71%	4.88%	5.01%	3.57%	2.04%	1.49%	1.35%	1.11%	0.9%
Selling, General & Admin	3.22M	2.98M	5.85M	10.41M	11.55M	13.82M	18.02M	18.44M	18.78M	24.62M
SG&A % of Revenue	4.67%	2.7%	3.75%	4.26%	3.01%	1.82%	1.3%	1.19%	0.98%	0.76%
Research & Development	869.13K	1.12M	1.75M	1.84M	2.16M	1.67M	2.56M	2.48M	2.64M	4.77M
R&D % of Revenue	1.26%	1.02%	1.12%	0.75%	0.56%	0.22%	0.18%	0.16%	0.14%	0.15%
Other Operating Expenses	0	0	0	0	0	0	-16.95K	-1.1K	0	0
Operating Income+	-3.53M	-3.28M	-6.55M	-10.53M	-10.8M	-10.5M	-10.27M	-10.67M	-8.23M	-6.21M
Operating Margin %	-5.12%	-2.97%	-4.2%	-4.31%	-2.81%	-1.38%	-0.74%	-0.69%	-0.43%	-0.19%
Operating Income Growth %	-0.29%	0.07%	-1%	-0.61%	-0.03%	0.03%	0.02%	-0.04%	0.23%	0.25%
EBITDA+	-3.53M	-3.27M	-6.54M	-10.46M	-10.7M	-10.39M	-9.93M	-10.13M	-7.71M	-5.43M
EBITDA Margin %	-5.12%	-2.96%	-4.19%	-4.28%	-2.79%	-1.37%	-0.72%	-0.65%	-0.4%	-0.17%
EBITDA Growth %	-0.29%	0.07%	-1%	-0.6%	-0.02%	0.03%	0.04%	-0.02%	0.24%	0.3%
D&A (Non-Cash Add-back)	5.31K	7.73K	11.41K	69.68K	95.12K	108.67K	335.96K	542.63K	517.68K	776.97K
EBIT	-3.53M	-3.28M	-6.55M	-10.53M	-10.8M	-11.09M	-10.27M	-10.67M	-8.23M	-5.82M
Net Interest Income+	0	-342.02K	-5.53M	175.41K	-113.63K	-474.71K	1.61K	88.73K	410.27K	388.59K
Interest Income	196.06K	0	0	0	-	0	1.61K	88.73K	410.27K	388.59K
Interest Expense	0	342.02K	358.92K	358.92K	113.63K	474.71K	0	0	0	0
Other Income/Expense	-196.06K	-342.02K	-5.55M	211.68K	81.99K	-1.06M	-15.34K	21.12K	239.99K	388.59K
Pretax Income+	-3.73M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.28M	-10.65M	-7.99M	-5.82M
Pretax Margin %	-5.41%	-3.28%	-7.76%	-4.22%	-2.79%	-1.52%	-0.74%	-0.68%	-0.42%	-0.18%
Income Tax+	0	0	0	0	0	0	88.93K	69.94K	156K	365.62K
Effective Tax Rate %	1.2%	1%	1%	1%	1%	1%	1.01%	1.01%	1.02%	1.06%
Net Income+	-4.48M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.37M	-10.72M	-8.15M	-6.18M
Net Margin %	-6.5%	-3.28%	-7.76%	-4.22%	-2.79%	-1.52%	-0.75%	-0.69%	-0.42%	-0.19%
Net Income Growth %	-0.27%	0.19%	-2.34%	0.15%	-0.04%	-0.08%	0.1%	-0.03%	0.24%	0.24%
Net Income (Continuing)	-3.73M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.37M	-10.72M	-8.15M	-6.18M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-134.56	-0.56	-84.05	-25.15	-19.20	-3.62	-1.78	-1.52	-0.28	-0.16
EPS Growth %	-0.27%	1%	-149.09%	0.7%	0.24%	0.81%	0.51%	0.15%	0.82%	0.43%
EPS (Basic)	-134.56	-0.56	-84.05	-25.18	-19.20	-3.62	-1.78	-1.52	-0.28	-0.16
Diluted Shares Outstanding	33.31K	6.41M	143.93K	410.15K	553.79K	3.33M	5.83M	7.05M	29.5M	37.76M
Basic Shares Outstanding	33.31K	6.41M	143.93K	409.75K	553.79K	3.33M	5.83M	7.05M	29.1M	37.76M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.37M	1.15M	13.85M	7.87M	6.15M	14.45M	19.09M	9.22M	13.65M	32.79M
Cash & Short-Term Investments	1.04M	797.17K	12.96M	6.54M	4.47M	12.24M	15.52M	5.35M	8.87M	24.87M
Cash Only	1.04M	797.17K	12.96M	6.54M	4.47M	12.24M	15.52M	5.35M	6.87M	24.37M
Short-Term Investments	0	0	0	0	0	0	0	0	1.99M	492.99K
Accounts Receivable	115.64K	114.51K	297.04K	382.26K	424.29K	924.92K	1.96M	1.9M	2.38M	3.83M
Days Sales Outstanding	61.2	37.88	69.55	57.09	40.35	44.52	51.63	44.49	45.2	42.89
Inventory	98.02K	82.44K	201.16K	256.15K	439.53K	707.11K	808.31K	1.4M	1.8M	3.17M
Days Inventory Outstanding	146.39	106.64	145.31	128.38	174.83	99.25	83.25	96.37	108.65	123.38
Other Current Assets	0	0	0	0	820.21K	0	-95.33K	573.46K	598.85K	933.38K
Total Non-Current Assets+	138.71K	511.8K	129.15K	407.1K	449.21K	263.81K	1M	946.55K	930.59K	9.45M
Property, Plant & Equipment	27.43K	21.56K	77.15K	187.51K	154.97K	263.81K	908.2K	703.03K	839.35K	8.91M
Fixed Asset Turnover	25.14x	51.17x	20.21x	13.03x	24.76x	28.75x	15.26x	22.13x	22.92x	3.65x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	52K	75K	75K	0	0	132.49K	0	0
Other Non-Current Assets	111.28K	490.24K	0	144.58K	219.24K	0	95.33K	111.03K	91.24K	539.41K
Total Assets+	1.51M	1.66M	13.97M	8.28M	6.6M	14.71M	20.1M	10.16M	14.58M	42.24M
Asset Turnover	0.46x	0.67x	0.11x	0.30x	0.58x	0.52x	0.69x	1.53x	1.32x	0.77x
Asset Growth %	-0.5%	0.1%	7.43%	-0.41%	-0.2%	1.23%	0.37%	-0.49%	0.43%	1.9%
Total Current Liabilities+	945.22K	3M	1.49M	1.86M	3.88M	2.87M	4.28M	3.6M	5.48M	10.17M
Accounts Payable	138.6K	311.08K	264.89K	426.73K	450.1K	180.5K	723.35K	569.68K	1.07M	1.17M
Days Payables Outstanding	206.99	402.41	191.35	213.87	179.04	25.34	74.5	39.22	64.67	45.59
Short-Term Debt	572.65K	2.07M	0	0	1.76M	0	0	0	0	0
Deferred Revenue (Current)	0	67.26K	168.01K	108.6K	2.95K	2.81K	192.75K	773.88K	8.51K	1000K
Other Current Liabilities	149.28K	248.56K	409.85K	292.6K	779.88K	2.08M	2.48M	1.19M	3.41M	5.14M
Current Ratio	1.45x	0.38x	9.32x	4.24x	1.58x	5.03x	4.46x	2.56x	2.49x	3.22x
Quick Ratio	1.35x	0.35x	9.19x	4.11x	1.47x	4.79x	4.27x	2.17x	2.16x	2.91x
Cash Conversion Cycle	0.6	-257.89	23.51	-28.4	36.15	118.44	60.38	101.64	89.18	120.68
Total Non-Current Liabilities+	1.9M	16.19M	44.04K	535.33K	890.46K	274.7K	402.87K	200.71K	115.16K	7.36M
Long-Term Debt	1.48M	3.38M	0	0	888.96K	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	155.15K	401.62K	200.21K	115.16K	7.36M
Deferred Tax Liabilities	0	0	0	0	888.96K	0	0	0	0	0
Other Non-Current Liabilities	425.33K	12.8M	0	0	0	118.06K	0	0	0	0
Total Liabilities	2.85M	19.19M	1.53M	1.86M	4.77M	3.14M	4.69M	3.8M	5.59M	17.53M
Total Debt+	2.05M	5.45M	0	0	2.65M	173.44K	735K	553.91K	601.3K	8.11M
Net Debt	1.01M	4.66M	-12.96M	-6.54M	-1.81M	-12.07M	-14.79M	-4.79M	-6.27M	-16.27M
Debt / Equity	-	-	-	-	1.45x	0.01x	0.05x	0.09x	0.07x	0.33x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-9.58x	-18.24x	-29.33x	-95.00x	-22.12x	-	-	-	-
Total Equity+	-1.34M	-17.53M	12.45M	6.43M	1.82M	11.57M	15.41M	6.36M	8.99M	24.71M
Equity Growth %	-2.88%	-12.1%	1.71%	-0.48%	-0.72%	5.34%	0.33%	-0.59%	0.41%	1.75%
Book Value per Share	-40.17	-2.73	86.47	15.67	3.29	3.47	2.64	0.90	0.30	0.65
Total Shareholders' Equity	-1.34M	-17.53M	12.45M	6.43M	1.82M	11.57M	15.41M	6.36M	8.99M	24.71M
Common Stock	100	112	1.11K	1.25K	57	457	687	775	2.71K	3.44K
Retained Earnings	-19.26M	-22.88M	-34.97M	-45.29M	-56.13M	-67.69M	-78.06M	-88.78M	-96.93M	-103.11M
Treasury Stock	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K	-6.46K
Accumulated OCI	0	-20.34K	-31.76K	-100.12K	0	-12.69K	-60.68K	43.23K	83.67K	-14.41K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-3.33M	-3.2M	-6.15M	-9.61M	-10.34M	-9.03M	-9.55M	-10.23M	-6.17M	-3.29M
Operating CF Margin %	-4.83%	-2.9%	-3.95%	-3.93%	-2.69%	-1.19%	-0.69%	-0.66%	-0.32%	-0.1%
Operating CF Growth %	-0.31%	0.04%	-0.92%	-0.56%	-0.08%	0.13%	-0.06%	-0.07%	0.4%	0.47%
Net Income	-3.73M	-3.62M	-12.1M	-10.32M	-10.71M	-11.56M	-10.37M	-10.72M	-8.15M	-6.18M
Depreciation & Amortization	5.31K	7.73K	11.41K	69.68K	95.12K	108.67K	335.96K	542.63K	517.68K	776.97K
Stock-Based Compensation	53.84K	94.09K	279.51K	814.67K	907.99K	614.3K	1.1M	1.19M	1.12M	874.44K
Deferred Taxes	0	0	-56.67K	48.92K	0	0	0	0	0	0
Other Non-Cash Items	-28.06K	5.35K	5.2M	-36.27K	-81.92K	959.13K	-19.73K	204.34K	48.31K	-17.37K
Working Capital Changes	363.96K	307.18K	505.97K	-186.57K	-550.01K	848.91K	-588.01K	-1.45M	293.21K	1.26M
Change in Receivables	115.99K	1.14K	-182.53K	-101.49K	-42.03K	-522.94K	-1.05M	47.45K	-495.6K	-1.56M
Change in Inventory	16.28K	120.59K	-161.07K	-140.82K	-213.56K	-271.55K	-118.22K	-607.4K	-384.78K	-1.4M
Change in Payables	0	364.17K	563.23K	466.19K	60.74K	1.22M	0	-711.9K	1.79M	4.69M
Cash from Investing+	-27.94K	-1.86K	-67K	-126.87K	-51.99K	-45.75K	-326.46K	-310.79K	-2.03M	259.98K
Capital Expenditures	-27.94K	-1.86K	-67K	-126.87K	-51.99K	-45.75K	-326.46K	-111.79K	-145.82K	-1.36M
CapEx % of Revenue	0.04%	0%	0.04%	0.05%	0.01%	0.01%	0.02%	0.01%	0.01%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	-126.87K	0	0	0	-199K	0	0
Cash from Financing+	1.98M	2.96M	18.38M	3.34M	8.32M	16.78M	13.17M	376.86K	9.71M	20.93M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	1.56M	2.87K	129.61K	3.34M	-73.38K	185.3K	12.07M	0	-8.12K	563.64K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-3.36M	-3.2M	-6.22M	-9.73M	-10.39M	-9.08M	-9.87M	-10.35M	-6.32M	-4.65M
FCF Margin %	-4.88%	-2.9%	-3.99%	-3.98%	-2.71%	-1.2%	-0.71%	-0.67%	-0.33%	-0.14%
FCF Growth %	-0.32%	0.05%	-0.94%	-0.56%	-0.07%	0.13%	-0.09%	-0.05%	0.39%	0.26%
FCF per Share	-100.95	-0.50	-43.22	-23.73	-18.77	-2.73	-1.69	-1.47	-0.21	-0.12
FCF Conversion (FCF/Net Income)	0.74x	0.89x	0.51x	0.93x	0.97x	0.78x	0.92x	0.95x	0.76x	0.53x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-97.2%	-109.34%	-259.69%	-172.72%	-76.9%	-98.5%	-106.17%	-36.7%
Return on Invested Capital (ROIC)	-	-	-	-	-	-	-13129.96%	-731.96%	-288.04%	-83.37%
Gross Margin	64.56%	74.42%	67.59%	70.2%	76.09%	65.71%	74.42%	65.91%	68.51%	71.23%
Net Margin	-649.9%	-327.84%	-776.04%	-422.11%	-279.15%	-152.49%	-74.86%	-68.92%	-42.34%	-19%
Debt / Equity	-	-	-	-	1.45x	0.01x	0.05x	0.09x	0.07x	0.33x
Interest Coverage	-	-9.58x	-18.24x	-29.33x	-95.00x	-22.12x	-	-	-	-
FCF Conversion	0.74x	0.89x	0.51x	0.93x	0.97x	0.78x	0.92x	0.95x	0.76x	0.53x
Revenue Growth	-24.48%	59.97%	41.29%	56.79%	57.02%	97.6%	82.72%	12.26%	23.7%	69.17%

Revenue by Segment

	2022	2023	2024
Product	14.56M	17.48M	32.55M
Product Growth	-	20.07%	86.26%
License	1M	1.76M	-
License Growth	-	76.49%	-

Frequently Asked Questions

Growth & Financials

Myomo, Inc. (MYO) reported $41.6M in revenue for fiscal year 2024. This represents a 4460% increase from $0.9M in 2014.

Myomo, Inc. (MYO) grew revenue by 69.2% over the past year. This is strong growth.

Myomo, Inc. (MYO) reported a net loss of $12.0M for fiscal year 2024.

Dividend & Returns

Myomo, Inc. (MYO) has a return on equity (ROE) of -36.7%. Negative ROE indicates the company is unprofitable.

Myomo, Inc. (MYO) had negative free cash flow of $13.8M in fiscal year 2024, likely due to heavy capital investments.